Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6551752 | 0.79 | ALDH1A1 (0.33) | ALDH1A1NPSR1 | |
| SCHEMBL453690 | 0.79 | NPSR1 (0.33) | ALDH1A1NPSR1MEN1CYP1A2CYP2C9 | |
| SCHEMBL10785435 | 0.77 | ALDH1A1 (0.38) | ALDH1A1NPSR1 | |
| SCHEMBL10783764 | 0.76 | CYP19A1 (0.44) | — | |
| SCHEMBL8996537 | 0.76 | MAPT (0.48) | ALDH1A1CYP2C19KMT2AMAPT | |
| SCHEMBL11216927 | 0.74 | — | — | |
| SCHEMBL4822714 | 0.72 | POLB (0.52) | ALDH1A1MAPT | |
| SCHEMBL10937315 | 0.71 | ALDH1A1 (0.33) | ALDH1A1NPSR1 | |
| SCHEMBL10937317 | 0.71 | ALDH1A1 (0.33) | ALDH1A1NPSR1 | |
| SCHEMBL11532435 | 0.71 | ALDH1A1 (0.33) | ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20140227201-A1 | Antimicrobial Gel Formulations | NOVABAY PHARMACEUTICALS, INC. | 2014-08-14 | — | — | US | claimed |
| JP-2012500209-A | — | — | 2012-01-05 | — | — | JP | claimed |
| EP-2312939-A1 | ANTIMICROBIAL GEL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-03-25 | — | — | US | claimed |
| WO-2010019723-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| US-6727221-B1 | APPLYING TO HUMAN SKIN A PERFUME COMPOSITION COMPRISING AT LEAST 50% BY WEIGHT OF PERFUME COMPONENTS HAVING A MINIMUM INHIBITORY CONCENTRATION (MIC) FOR CORYNEFORM BACTERIA OF GREATER THAN 0.1% | QUEST INTERNATIONAL B.V. (NL) | 2004-04-27 | — | — | US | claimed |
| EP-1094784-B1 | PERFUME COMPOSITION | QUEST INT (NL) | 2004-02-11 | — | — | EP | claimed |
| EP-1094784-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2001-05-02 | — | — | EP | claimed |
| WO-2000001352-A1 | PERFUME COMPOSITION | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
| WO-1993021295-A1 | LIQUID OR GEL BLEACHING COMPOSITION CONTAINING AMIDOPEROXYACID BLEACH AND PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| WO-1993021296-A1 | AQUEOUS LIQUID BLEACH COMPOSITIONS WITH FLUORESCENT WHITENING AGENT AND POLYVINYL PYRROLIDONE OR POLYVINYL ALCOHOL | THE PROCTER & GAMBLE COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| US-5248434-A | Stability | THE PROCTOR & GAMBLE COMPANY (US) | 1993-09-28 | — | — | US | claimed |
| US-5234617-A | Cleaning, bleaching fabrics | Hunter, Kathleen B. (US) | 1993-08-10 | — | — | US | claimed |
| US-12461089-B2 | Olfactory receptor involved in the perception of musk fragrance and the use thereof | CHEMOSENSORYX BIOSCIENCES SA (BE) | 2025-11-04 | — | — | US | disclosed |
| US-20240319168-A1 | OLFACTORY RECEPTOR INVOLVED IN THE PERCEPTION OF MUSK FRAGRANCE AND THE USE THEREOF | CHEMOSENSORYX BIOSCIENCES SA (BE) | 2024-09-26 | — | — | US | disclosed |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-02-08 | — | — | US | disclosed |
| US-5248434-A | Stability | THE PROCTOR & GAMBLE COMPANY (US) | 1993-09-28 | — | — | US | disclosed |
| US-5234617-A | Cleaning, bleaching fabrics | Hunter, Kathleen B. (US) | 1993-08-10 | — | — | US | disclosed |
| US-4442025-A | Perfume compositions and perfumed articles containing esters of substituted bicyclo [2.2.1]heptane and heptene-carboxylic acids as perfume base | NAARDEN INTERNATIONAL, N.V. (NL) | 1984-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140227201-A1 | Antimicrobial Gel Formulations | CUTA, TUBA3C, POLR1C | CHRNB2 4829/4885CHRNB4 4839/4885CHRNA3 4713/4885 |
| US-20240041752-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | AOX1, TYR, OCIAD1 | CHRNB2 3601/4885CHRNB4 3932/4885CHRNA3 4535/4885 |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | CUTA, TUBA3C, POLR1C | CHRNB2 4829/4885CHRNB4 4839/4885CHRNA3 4713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.